Effectiveness of condoms in preventing sexually transmitted infections

Bulletin of the World Health Organization

Volumn 82, Issue 6, 2004, Pages 454-461

  Holmes, King K ^a   Levine, Ruth ^a   Weaver, Marcia ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Chlamydia infections prevention and control; Condoms utilization; Gonorrhea prevention and control; Herpes genitalis prevention and control; Sexually transmitted diseases prevention and control; Trichomonas vaginitis prevention and control

Indexed keywords

CONDOM USE; DISEASE CONTROL; DISEASE TRANSMISSION; SEXUALLY TRANSMITTED DISEASE;

ADOLESCENT; ADULT; CANCER REGRESSION; CHLAMYDIASIS; CONDOM; FEMALE; GONORRHEA; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION PREVENTION; INFECTION RISK; MALE; NONHUMAN; PENIS INJURY; REVIEW; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; SYSTEMATIC REVIEW; TRICHOMONIASIS; UNITED STATES; UTERINE CERVIX CARCINOMA IN SITU; VIRUS TRANSMISSION; WART VIRUS;

CONDOMS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; NATIONAL INSTITUTES OF HEALTH (U.S.); PROGRAM EVALUATION; PUBLIC HEALTH; SEXUALLY TRANSMITTED DISEASES; UNITED STATES;

EID: 3042574047     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Hitchcock P. Scientific evidence on condom effectiveness for sexually transmitted disease (STD) prevention: workshop summary. Herndon (VA): DIANE Publishing, 2001. (From a workshop held by the US National Institute of Allergy and Infectious Diseases, NIH, June 12-13, 2001.)
2. Davis KR, Weller SC. The effectiveness of condoms in reducing heterosexual transmission of HIV. Family Planning Perspectives 1999;31:272-9.
3. Weller S, Davis K. Condom effectiveness in reducing heterosexual HIV transmission. Issue 1. Oxford: Update Software; 2004. (Cochrane review.)
4. Hooper RR, Reynolds GH, Jones OG, Zaidi A, Wiesner PJ, Latimer KP, et al. Cohort study of venereal disease. 1: The risk of gonorrhea transmission from infected women to men. American Journal of Epidemiology 1978;108:136-44.
5. Cates WC, Holmes KK. Condom efficacy against gonorrhea and nongonococcal urethritis. [Letter to the editor.] American Journal of Epidemiology 1996;143:843-4.
6. Cates W. The NIH condom report: the glass is 90% full. Family Planning Perspectives 2001;33:231-3.
7. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR Morbidity and Mortality Weekly Report 2002;51(RR-6):1-78.
8. World Health Organization. Guidelines for the management of sexually transmitted infections. Geneva: World Health Organization; 2003. (Also available from: http://www.who.int/reproductive-health/publications/rhr_01_10/01_10.pdf.)
9. Hearst N, Chen S. Condoms for AIDS prevention in the developing world: is it working? Studies in Family Planning 2004;35:39-47.
10. Ahmed S, Lutalo T, Wawer M, Serwadda D, Sewankambo NK, Nalugoda F, et al. HIV incidence and sexually transmitted disease prevalence associated with condom use: a population study in Rakai, Uganda. AIDS 2001;15:2171-9.
11. Pinkerton SD, Abramson PR. Effectiveness of condoms in preventing HIV transmission. Social Science and Medicine 1997;44:1303-12.
12. Wald A, Langenberg AGM, Link K, Izu AE, Ashley R, Warren T, et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA 2001;285:3100-6.
13. Sanchez J, Campos PE, Courtois B, Gutierrez L, Carrillo C, Alarcon J, et al. Prevention of sexually transmitted diseases (STDs) in female sex workers: prospective evaluation of condom promotion and strengthened STD services. Sexually Transmitted Diseases 2003;30:273-9.
14. Crosby RA, DiClemente RJ, Wingood GM, Lang D, Harrington KF. Value of consistent condom use: a study of sexually transmitted disease prevention among African American adolescent females. American Journal of Public Health 2003;93:901-2.
15. Bunnell RE, Dahlberg L, Rolfs R, Ransom R, Gershman K, Farshy C, et al. High prevalence and incidence of sexually transmitted diseases in urban adolescent females despite moderate risk behaviors. Journal of Infectious Diseases 1999;180:1624-31.
16. Zenilman JM, Weisman CS, Rompalo AM, Ellish N, Upchurch DM, Hook EW, et al. Condom use to prevent incident STDS: the validity of self-reported condom use. Sexually Transmitted Diseases 1995;22:15-21.
17. Ho GYF, Bierman R, Beardsley NP, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. New England Journal of Medicine 1998;338:423-8.
18. Zondervan KT, Carpenter LM, Painter R, Vessey MP. Oral contraceptives and cervical cancer - further findings from the Oxford Family Planning Association contraceptive study. British Journal of Cancer 1996;73:1291-7.
19. Winer RL, Lee S-K, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. American Journal of Epidemiology 2003;157:218-26.
20. Hogewoning C, Bleeker M, Van den Brule A, Voorhorst F, Snijders P, Berkhof J, et al. Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papilloma virus: a randomized clinical trial. International Journal of Cancer 2003;107;811-16.
21. Bleeker M, Hogewoning C, Voorhorst F, Van den Brule A, Snijders P, Starink T, et al. Condom use promotes regression of human papillomavirus- associated penile lesions in male sexual partners of women with cervical intraepithelial neoplasia. International Journal of Cancer 2003;107;804-10.
22. Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sexually Transmitted Diseases 2002;29:725-35.
23. Devine OJ, Aral SO. The impact of inaccurate reporting of condom use and imperfect diagnosis of STD infection in studies of condom effectiveness: A simulation-based assessment. Sexually Transmitted Diseases. In press 2004.
24. Warner L, Clay-Warner J, Boles J, Williamson J. Assessing condom use practices: implications for evaluating method and user effectiveness. Sexually Transmitted Diseases 1998;25:273-7.
25. Warner L, Newman DR, Austin HD, Kamb ML, Douglas JM, Malotte CK, et al. Condom effectiveness for reducing transmission of gonorrhea and chlamydia: the importance of assessing partner infection status. American Journal of Epidemiology 2004;159;242-51.
26. Fitch JT, Stine C, Hager D, Mann J, Adam MB, Mcilhaney J. Condom effectiveness: factors that influence risk reduction. Sexually Transmitted Diseases 2002;29:811-7.
27. Crosby RA, DiClemente RJ, Holtgrave DR, Wingood GM. Design, measurement, and analytical considerations for testing hypotheses relative to condom effectiveness against non-viral STIs. Sexually Transmitted Infections 2002;78:228-31.
28. Manhart LE, Holmes KK. Randomized controlled trials of individual, population, and multilevel interventions for preventing sexually transmitted infections: what has worked? Journal of Infectious Diseases. In press 2004.
29. Kamb ML, Fishbein M, Douglas JM Jr, Rhodes F, Rogers J, Bolan G, et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. JAMA 1998;280:1161-7. (Project RESPECT Study Group.)
30. Shain RN, Piper JM, Newton ER, Perdue ST, Ramos R, Champion JD, et al. A randomized, controlled trial of a behavioral intervention to prevent sexually transmitted disease among minority women. New England Journal of Medicine 1999;340:93-100.
31. Baker SA, Beadnell B, Stoner S, Morrison DM, Gordon J, Collier C, et al. Skills training versus health education to prevent STDs/HIV in heterosexual women: a randomized controlled trial utilizing biological outcomes. AIDS Education and Prevention 2003;15:1-14.
32. Shain RN, Perdue ST, Piper JM, Holden AE, Champion JD, Newton ER, et al. Behaviors changed by intervention are associated with reduced STD recurrence: the importance of context in measurement. Sexually Transmitted Diseases 2002;29:520-9.
33. Voluntary HIV-1 Counseling and Testing Efficacy Study Group. Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: a randomized trial. Lancet 2000;356:103-12.
34. Celentano DD, Bond KC, Lyles CM, Eiumtrakul S, Go VF, Beyrer C, et al. Preventive interventions to reduce sexually transmitted infections: a field trial in the Royal Thai Army. Archives of Internal Medicine 2000;160:535-40.
35. Imrie J, Stephenson JM, Cowan FM, Wanigaratne S, Billington AJ, Copas AJ, et al. A cognitive behavioural intervention to reduce sexually transmitted infections among gay men: randomised trial. BMJ 2001;322:1451-6.
36. Anderson RM, Garnett GP. Low efficacy HIV vaccines: potential for community intervention trials. Lancet 1996;348:1010-3.
37. United States Agency for International Development (USAID). The ABCs of HIV prevention. January 2004, available from http://www.usaid.gov/pop_health/ aids/News/abcfactsheet.html
38. Shelton JD, Halperin DT, Nantulya V, Potts M, Gayle HD, Holmes KK. Partner reduction is crucial for balanced "ABC" approach to HIV Prevention. BMJ 2004;328:891-3.